Impairment of cardiac neuronal function in childhood dilated cardiomyopathy: An 123I-MIBG scintigraphic study

Journal of Nuclear Medicine

Volumn 41, Issue 3, 2000, Pages 400-404

  Maunoury, Christophe ^a   Agostini, Denis ^b   Acar, Philippe ^b   Antonietti, Thierry ^b   Sidi, Daniel ^b   Bouvard, Gérard ^b   Kachaner, Jean ^b   Barritault, Lionel ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

Cardiac neuronal function; Cardiomyopathy; Metaiodobenzylguanidine; Pediatrics; Scintigraphy

Indexed keywords

GUANETHIDINE; GUANIDINE DERIVATIVE; IODINE 123; METALODOBENZYLGUANIDINE IODINE 123; NORADRENALIN; TRACER; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HEART DILATATION; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCINTIGRAPHY;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART; HUMANS; INFANT; IODINE RADIOISOTOPES; MALE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034102020     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Schofer J, Spielmann R, Schubert A, Weber K, Schluter M. Iodine-123 metaiobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988;12:1252-1258.
2. Merlet P, Dubois-Randé JL, Adnot S, et al. Myocardial β-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol. 1992;19:10-16.
3. Merlet P, Valette H, Dubois-Randé JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
4. Yamakado K, Takeda K, Kitano T, et al. Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy. Eur J Nucl Med. 1992;19:265-270.
5. Imamura Y, Ando H, Mitsuoka W, et al. Iodine-123-metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 1995;26:1594-1599.
6. Agostini D, Scanu P, Babatasi G, et al. Pheochromocytoma with catecholamine-induced impairment of cardiac neuronal function. Am Heart J. 1995;130:1128-1130.
7. Harris LC, Rodin AE, Nghiem QX. Idiopathic nonobstructive cardiomyopathy in children. Am J Cardiol. 1968;21:153-165.
8. Greenwood RD, Nadas AS, Fyler DC. The clinical course of primary myocardial disease in infants and children. Am Heart J. 1976;92:549-560.
9. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol. 1985;6:1126-1131.
10. Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. 1988;11:139-144.
11. Chen S, Noun S, Balfour I, Jureidini S, Appleton RS. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol. 1990;15:189-193.
12. Guntheroth WG. Congestive cardiomyopathy in children. J Am Coll Cardiol. 1990;15:194-195.
13. Friedman RA, Moak JP, Garson A. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol. 1991;18:152-156.
14. Gersony WM. The child with dilated cardiomyopathy: prognostic considerations and management decisions. J Am Coll Cardiol. 1991;18:157-158.
15. Wiles HB, McArthur PD, Taylor AB, et al. Prognostic features of children with idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;68:1372-1376.
16. Akagi T, Benson LN, Lightfoot NE, Chin K, Wilson G, Freedom RM. Natural history of dilated cardiomyopathy in children. Am Heart J. 1991;121:1502-1506.
17. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy. Circulation. 1994;90:1310-1318.
18. Wieland DM, Brown LE, Rogers WL, et al. Myocardial imaging with radioiodinated norepinephrine storage analog. J Nucl Med. 1981;22:22-31.
19. Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med. 1981;22:129-132.
20. Sisson JC, Shapiro B, Meyers L, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 1987;28:1625-1636.
21. Estorch M, Carrio I, Berna L, Lopez-Pousa J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol. 1995;2:126-132.
22. Morozumi T, Kusuoka H, Fukuchi K, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med. 1997;38:49-52.
23. 123I]-MIBG) in patients with myocardial infarct. Eur J Nucl Med. 1989;15:624-628.
24. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol. 1991;17:1416-1423.
25. Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988;78: 1192-1199.
26. Agostini D, Lecluse E, Belin A, et al. Impact of exercise rehabilitation on cardiac neuronal function in heart failure: an iodine-123-metaiodobenzylguanidine scintigraphy study. Eur J Nucl Med. 1998;25:235-241.
27. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med. 1989;30:1182-1191.
28. Dae MW, De Marco T, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: implications for clinical studies. J Nucl Med. 1992;33:1444-1450.
29. 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol. 1996;3:508-515.
30. 123I]metaiodobenzylguanidine. Diabetes. 1992;41:1069-1075.
31. Kondo C, Nakazawa M, Momma K, Kusakabe K. Sympathetic denervation and reinnervation after arterial switch operation for complete transposition. Circulation. 1998,97:2414-2419.
32. Wu JR, Chang HR, Chen SS, Huang TY. Circulating noradrenaline and beta-adrenergic receptors in children with congestive heart failure. Acta Paediatr. 1996;85:923-927.
33. Huguet F, Fagret D, Caillet M, Piriou A, Besnard JC, Guilloteau D. Interaction of metaiodobenzylguanidine with cardioactive drugs: an in vitro study. Eur J Nucl Med. 1996;23:546-549.
34. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med. 1997;38: 1085-1089.
35. 123I]metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart. 1996;76:218-222.